These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception. Pertovaara A, Kauppila T, Jyväsjärvi E, Kalso E. Neuroscience; 1991; 44(3):705-14. PubMed ID: 1684411 [Abstract] [Full Text] [Related]
4. Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies. Pertovaara A. Prog Neurobiol; 1993 Jun; 40(6):691-709. PubMed ID: 8097888 [Abstract] [Full Text] [Related]
5. The antinociceptive action of an alpha 2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition. Hämäläinen MM, Pertovaara A. Brain Res Bull; 1995 Jun; 37(6):581-7. PubMed ID: 7670881 [Abstract] [Full Text] [Related]
9. Dissociation of the alpha 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats. Pertovaara A, Hämäläinen MM, Kauppila T, Mecke E, Carlson S. Pain; 1994 May; 57(2):207-215. PubMed ID: 7916451 [Abstract] [Full Text] [Related]
10. Influence of selective alpha 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats. Mansikka H, Pertovaara A. Eur J Pharmacol; 1995 Jul 25; 281(1):43-8. PubMed ID: 8566115 [Abstract] [Full Text] [Related]
11. Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats. Graham BA, Hammond DL, Proudfit HK. J Pharmacol Exp Ther; 1997 Nov 25; 283(2):511-9. PubMed ID: 9353364 [Abstract] [Full Text] [Related]
12. Different roles of alpha 2-adrenoceptors of the medulla versus the spinal cord in modulation of mustard oil-induced central hyperalgesia in rats. Mansikka H, Idänpään-Heikkilä JJ, Pertovaara A. Eur J Pharmacol; 1996 Feb 15; 297(1-2):19-26. PubMed ID: 8851161 [Abstract] [Full Text] [Related]
13. Antinociception in bulboreticular neurons of the rat produced by spinally administered medetomidine, an alpha 2-adrenoceptor agonist. Pertovaara A. Eur J Pharmacol; 1991 Oct 29; 204(1):9-14. PubMed ID: 1687126 [Abstract] [Full Text] [Related]
14. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli. Idänpään-Heikkilä JJ, Kalso EA, Seppälä T. J Pharmacol Exp Ther; 1994 Dec 29; 271(3):1306-13. PubMed ID: 7996439 [Abstract] [Full Text] [Related]
15. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Ossipov MH, Harris S, Lloyd P, Messineo E, Lin BS, Bagley J. Anesthesiology; 1990 Dec 29; 73(6):1227-35. PubMed ID: 1978990 [Abstract] [Full Text] [Related]
16. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist. Kalso EA, Pöyhiä R, Rosenberg PH. Pharmacol Toxicol; 1991 Feb 29; 68(2):140-3. PubMed ID: 1677190 [Abstract] [Full Text] [Related]
17. Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats. Meert TF, De Kock M. Anesthesiology; 1994 Sep 29; 81(3):677-88. PubMed ID: 7916547 [Abstract] [Full Text] [Related]
18. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat. Wei H, Pertovaara A. Anesth Analg; 1997 Nov 29; 85(5):1122-7. PubMed ID: 9356112 [Abstract] [Full Text] [Related]
19. Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF. Kontinen VK, Kalso EA. Peptides; 1995 Nov 29; 16(5):973-7. PubMed ID: 7479344 [Abstract] [Full Text] [Related]
20. Mydriatic and antinociceptive effects of intrathecal dexmedetomidine in conscious rats. Horváth G, Kovács M, Szikszay M, Benedek G. Eur J Pharmacol; 1994 Feb 21; 253(1-2):61-6. PubMed ID: 7912198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]